Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
BLACKROCK INC BLK |
1,673,483 7.800% |
-261,228 (-13.50%) |
Filing History |
| 2025-02-14 5:05 pm Purchase |
2025-02-12 | 13D | Enanta Pharmaceuticals, Inc. ENTA |
Jay R. Luly, Ph.D. | 1,703,616 7.700% |
337,298 (+24.69%) |
Filing History |
| 2025-02-11 12:11 pm Purchase |
2024-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
FARALLON CAPITAL PARTNERS LP | 2,108,262 9.900% |
83,262 (+4.11%) |
Filing History |
| 2025-01-22 4:01 pm Purchase |
2025-01-14 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Integrated Core Strategies (US) LLC | 1,382,273 6.500% |
1,382,273 (New Position) |
Filing History |
| 2024-11-14 4:03 pm Sale |
2024-09-30 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Armistice Capital, LLC | 1,000,000 4.720% |
-1,064,000 (-51.55%) |
Filing History |
| 2024-10-17 4:31 pm Sale |
2024-09-30 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
MILLENNIUM MANAGEMENT LLC | 731,295 3.500% |
-583,654 (-44.39%) |
Filing History |
| 2024-02-27 1:11 pm Purchase |
2024-02-22 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Krensavage Asset Management LLC | 1,086,024 5.100% |
1,086,024 (New Position) |
Filing History |
| 2024-02-14 2:26 pm Sale |
2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Armistice Capital, LLC | 2,064,000 9.800% |
-14,000 (-0.67%) |
Filing History |
| 2024-02-13 5:04 pm Purchase |
2023-12-29 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
The Vanguard Group | 1,793,786 8.520% |
271,597 (+17.84%) |
Filing History |
| 2024-01-26 09:11 am Purchase |
2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
FARALLON CAPITAL PARTNERS LP | 2,025,000 9.600% |
475,000 (+30.65%) |
Filing History |
| 2024-01-24 5:23 pm Sale |
2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
BLACKROCK INC BLK |
1,934,711 9.200% |
-43,300 (-2.19%) |
Filing History |
| 2024-01-22 12:25 pm Sale |
2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
STATE STREET CORP STT |
425,640 2.020% |
-1,086,552 (-71.85%) |
Filing History |
| 2024-01-11 4:15 pm Purchase |
2024-01-05 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
MILLENNIUM MANAGEMENT LLC | 1,314,949 6.200% |
290,273 (+28.33%) |
Filing History |
| 2023-11-16 4:31 pm Purchase |
2023-11-07 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
MILLENNIUM MANAGEMENT LLC | 1,024,676 4.900% |
1,024,676 (New Position) |
Filing History |
| 2023-10-06 2:34 pm Sale |
2023-09-30 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
BLACKROCK INC BLK |
1,978,011 9.400% |
-1,775,064 (-47.30%) |
Filing History |
| 2023-02-14 2:31 pm Sale |
2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
FIRST MANHATTAN CO | 243,718 1.170% |
-865,118 (-78.02%) |
Filing History |
| 2023-02-14 12:39 pm Purchase |
2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Armistice Capital, LLC | 2,078,000 9.990% |
1,022,000 (+96.78%) |
Filing History |
| 2023-02-09 11:19 am Sale |
2022-12-30 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
The Vanguard Group | 1,522,189 7.320% |
-103,720 (-6.38%) |
Filing History |
| 2023-02-08 1:17 pm Purchase |
2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
STATE STREET CORP STT |
1,512,192 7.270% |
385,123 (+34.17%) |
Filing History |
| 2023-02-06 09:06 am Purchase |
2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
FARALLON CAPITAL PARTNERS LP | 1,550,000 7.500% |
1,550,000 (New Position) |
Filing History |